Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma

D.E.S. Lustgarten; C. Deshpande; C. Aggarwal; L.-C. Wang; V. Saloura; A. Vachani; L.-P. Wang; L. Litzky; M. Feldman; Jenette Creaney; Anna Nowak; C. Langer; S. Inghilleri; G. Stella; S.M. Albelda

doi:10.1097/JTO.0b013e318283da3e

Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma

D.E.S. Lustgarten, C. Deshpande, C. Aggarwal, L.-C. Wang, V. Saloura, A. Vachani, L.-P. Wang, L. Litzky, M. Feldman, Jenette Creaney, Anna Nowak, C. Langer, S. Inghilleri, G. Stella, S.M. Albelda

Graduate Research School

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	469-477
Journal	Journal of Thoracic Oncology
Volume	8
DOIs	https://doi.org/10.1097/JTO.0b013e318283da3e
Publication status	Published - 2013

Access to Document

10.1097/JTO.0b013e318283da3e

Cite this

Lustgarten, D. E. S., Deshpande, C., Aggarwal, C., Wang, L-C., Saloura, V., Vachani, A., Wang, L-P., Litzky, L., Feldman, M., Creaney, J., Nowak, A., Langer, C., Inghilleri, S., Stella, G., & Albelda, S. M. (2013). Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma. Journal of Thoracic Oncology, 8, 469-477. https://doi.org/10.1097/JTO.0b013e318283da3e

@article{a2ec4d0a7f264469a24491865b79c700,

title = "Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma",

author = "D.E.S. Lustgarten and C. Deshpande and C. Aggarwal and L.-C. Wang and V. Saloura and A. Vachani and L.-P. Wang and L. Litzky and M. Feldman and Jenette Creaney and Anna Nowak and C. Langer and S. Inghilleri and G. Stella and S.M. Albelda",

year = "2013",

doi = "10.1097/JTO.0b013e318283da3e",

language = "English",

volume = "8",

pages = "469--477",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Academic Press",

}

Lustgarten, DES, Deshpande, C, Aggarwal, C, Wang, L-C, Saloura, V, Vachani, A, Wang, L-P, Litzky, L, Feldman, M, Creaney, J , Nowak, A, Langer, C, Inghilleri, S, Stella, G & Albelda, SM 2013, 'Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma', Journal of Thoracic Oncology, vol. 8, pp. 469-477. https://doi.org/10.1097/JTO.0b013e318283da3e

TY - JOUR

T1 - Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma

AU - Lustgarten, D.E.S.

AU - Deshpande, C.

AU - Aggarwal, C.

AU - Wang, L.-C.

AU - Saloura, V.

AU - Vachani, A.

AU - Wang, L.-P.

AU - Litzky, L.

AU - Feldman, M.

AU - Creaney, Jenette

AU - Nowak, Anna

AU - Langer, C.

AU - Inghilleri, S.

AU - Stella, G.

AU - Albelda, S.M.

PY - 2013

Y1 - 2013

U2 - 10.1097/JTO.0b013e318283da3e

DO - 10.1097/JTO.0b013e318283da3e

M3 - Article

C2 - 23486267

VL - 8

SP - 469

EP - 477

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

ER -